`IPR2014-01089
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`GLOBALFOUNDRIES U.S., INC., GLOBALFOUNDRIES DRESDEN
`MODULE ONE LLC & CO. KG, GLOBALFOUNDRIES DRESDEN
`MODULE TWO LLC & CO. KG, and THE GILLETTE COMPANY,
`
`Petitioners
`v.
`ZOND, LLC
`Patent Owner
`_____________________
`
`Inter Partes Review Case No. IPR2014-010891
`
`Patent 6,806,652
`
`____________________
`
`
`PATENT OWNER’S OBSERVATIONS ON CROSS-EXAMINATION
`OF PETITIONER’S REPLY WITNESS
`
`37 C.F.R. §42.70
`
`
`
`
`
`
`
`
`1 Case IPR2014-01004 has been joined with the instant proceeding.
`
`
`
`
`Patent No. 6,806,652
`IPR2014-01089
`
`
`
`Pursuant to 37 C.F.R. §42.70(a), Patent Owner, Zond, LLC, hereby
`
`submits it observations on cross-examination of Dr. Korthsagen, whose
`
`Declaration was submitted by Petitioners with their Reply Brief filed June 26,
`
`2015. Dr. Kortshagen’s cross-examination was conducted by deposition on
`
`July 2, 2015. Exhibit 2004 is a transcript of that deposition, and is used as the
`
`basis for the present observations.
`
`1. Dr. Kortshagen Testified that Mozgrin’s Regions 2 and 3 Both
`Represent Areas of High-Density Plasma.
`
`
`
`Claim 35 of the ‘652 patent requires “means for super-ionizing the initial
`
`plasma … thereby generating a high-density plasma.”2 Dr. Kortshagen
`
`testified that region 1 of Mozgrin’s Fig. 4 is representative of such an initial
`
`plasma created by a preexcitation unit.3 Dr. Kortshagen further testified that
`
`region 2 of Mozgrin’s Figure 4 represents an area of high-density plasma,4 and
`
`that region 3 of Mozgrin’s Figure 4 also represents an area of high-density
`
`
`2 Ex. 1001 at 36:20 -22.
`
`3 Ex. 2004 at 22:16-24:18 (testifying that region 1 shown in Mozgrin’s Figure 4
`
`represents a pre-ionization stage, with an initial plasma having a density in the
`
`range 107 – 109 cm-3).
`
`4 Id. at 26:3-21; 28:7-17.
`
`
`
`1
`
`
`
`Patent No. 6,806,652
`IPR2014-01089
`
`plasma.5 This testimony is relevant because it contradicts Petitioner’s argument
`
`that Mozgrin teaches “means for super-ionizing the initial plasma … thereby
`
`generating a high-density plasma.”6
`
`In an attempt to show “super-ionization” of the initial plasma, Dr.
`
`Kortshagen and Petitioners rely on computations that discuss the plasma
`
`densities during a transition from Mozgrin’s region 2 to region 3.7 For
`
`example, Dr. Kortshagen states that “‘for the discharge transit from regime 2
`
`to regime 3 . . . the ionization degree α = ne / (ng + ni) ranges from α ≈ 1 (p =
`
`0.01 torr) to α ≈ 0.7 (p = 1torr).’”8 However, Dr. Korshagen’s deposition
`
`testimony reveals that such a transition is not super-ionizing the initial plasma
`
`to thereby generate a high density plasma, as required by claim 35, rather it is
`
`further ionizing an already high-density plasma. That is, Dr. Kortshagen’s
`
`reliance on the densities reported by Mozgrin for a “discharge transit from
`
`regime 2 to regime 3” do not support “converting at least 75% of the neutral
`
`
`5 Id. at 28:19 – 29:8.
`
`6 Reply Brief at 2 et seq.
`
`7 Ex. 1216 at ¶ 31; Reply Brief at 11 - 13, 20 - 21.
`
`8 Ex. 1216 at ¶ 31 quoting Mozgrin at 407, left col. ¶ 2 and right col. ¶ 3 (emphasis
`
`in original).
`
`
`
`2
`
`
`
`Patent No. 6,806,652
`IPR2014-01089
`
`atoms in the initial plasma into ions,”9 as the Board has determined is required
`
`by the claim. Rather, the “discharge transit from regime 2 to regime 3”
`
`represents ionization of an already dense plasma, not ionization of an initial
`
`plasma to thereby generate a high density plasma.
`
`2. Dr. Kortshagen Testified that He Could Not Determine Whether
`Iwamura’s Preexcitaiton Unit Generated a Weakly-Ionized
`Plasma.
`
`
`
`During cross-examination, Dr. Kortshagen testified that he could not
`
`determine whether Iwamura’s pre-excitation unit creates a weakly-ionized
`
`plasma as defined in the ‘652 Patent.10 This testimony is relevant because it
`
`contradicts Petitioner’s argument that claim 35 is obvious in view of the cited
`
`references.11
`
`
`
`
`9 Globalfoundries U.S., Inc. et al. v. Zond, LLC, IPR2014-01088, Paper 16, p. 11
`
`(P.T.A.B. Jan. 6, 2015).
`
`10 Ex. 2004 at 54:2-10.
`
`11 Pet. at 54 et seq.
`
`
`
`3
`
`
`
`Patent No. 6,806,652
`IPR2014-01089
`
`3. Dr. Kortshagen’s Testimony Confirms that Iwamura’s Objective was
`to Treat an Object with “Active” Neutral Gas Atoms or Molecules,
`While Reducing the Risk of Damage by Ions.
`
`
`
`In his testimony,12 Dr. Korthsagen confirmed that Iwamura’s goal was to
`
`treat an object with electrically neutral “activated species,” while minimizing
`
`damage to the object caused by ions that are generated along with the activated
`
`species. This is relevant to Patent Owner’s argument that the purpose of
`
`Iwamura’s two-stage system is NOT to super-ionize an initial plasma,13 and
`
`that Iwamura’s teaching is in fact contrary to this objective of the invention.
`
`First, Dr. Kortshagen explained that the “activated species” described by
`
`Iwamura are electrically neutral atoms/molecules that are in an excited energy
`
`state:14
`
`Q. Do you have an understanding of what Iwamura means
`
`by the term "activated gas species"?
`
`THE WITNESS: I believe what Iwamura refers to with
`
`"activated gas species" is can include excited atoms, excited
`
`molecules, potentially fragmented molecules, which would
`
`be called radicals.
`
`
`12 Ex. 2004 at 63:6 – 72:6; 76:6-16; 78:3 – 79:14.
`
`13 Patent Owner’s Opposition at 27.
`
`14 Id. at 60:4-16.
`
`
`
`4
`
`
`
`Patent No. 6,806,652
`IPR2014-01089
`
`BY MR. FAHMI:
`
`Q. Are all of these electrically neutral?
`
`A. Yes, all of the ones that I named are electrically neutral.
`
`Dr. Kortshagen then confirmed that Iwamura’s goal was to treat a substrate or
`
`object with such electrically neutral molecules that are formed by a plasma:
`
`Q. Yes. So, generally, then, Iwamura's goal is to treat the
`
`substrate or the object to be treated with the activated gas
`
`species that are formed by the plasma in order to improve
`
`the yield of the treatment, correct?
`
`. . .
`
`THE WITNESS: Yes, I believe that this is a fair statement,
`yes.15
`
`Dr. Kortshagen further testified that Iwamura discloses two techniques for
`
`reducing the damage caused by charged particles in the plasma so as to limit
`
`damage to the object by the ions16 - both of which are contrary to the claimed
`
`objective of super-ionizing a plasma. Dr. Korshagen confirmed that the first of
`
`these techniques removed the majority of charged particles from the plasma17
`
`(thus reducing plasma density), and that the other technique reduced the
`
`power in the down-stream stage (which also is contrary to the claimed
`
`
`15 Id. at 64:19 – 65:3; see also, id. at 78:3-14.
`
`16 Id. at 76:6-16; 69:9 – 72: 6.
`
`17 Id. at 76:6-16.
`
`
`
`5
`
`
`
`Patent No. 6,806,652
`IPR2014-01089
`
`objective of super-ionizating the initial plasma to thereby generate a high
`
`density plasma).18 All of this confirms Patent Owner’s explanation that the
`
`purpose of Iwamura’s two-stage system is NOT to super-ionize the initial
`
`plasma, and that Iwmura’s teachings are contrary to this objective.
`
`
`
`
`
`4. Dr. Kortshagen Confirmed that Fahey Does Not Teach Super-
`Ionization.
`
`Dr. Kortshagen’s testimony confirms Patent Owner’s characterization19 that
`
`the purpose of Fahey’s device was not to produce a high-density plasma, as
`
`claimed, but instead to produce electrically neutral, metastable atoms. Indeed,
`
`Dr. Kortshagen admitted that “it is correct that Fahey is a reference that is not
`
`geared towards super-ionization . . . .”20
`
`
`
`
`18 Id. at 69:9 – 72: 6; see 94:24 – 96:4 regarding the use of high power in the ‘652
`
`patent for super-ionization.
`
`19 Patent Owner’s Opposition at 22-23.
`
`20 Ex. 2004 at 86:13 – 18 (emphasis added).
`
`
`
`6
`
`
`
`Patent No. 6,806,652
`IPR2014-01089
`
`
`
`
`
`Respectfully submitted,
`
`
`/Bruce Barker/
`Bruce Barker; Reg. No. 33,291
`Chao Hadidi Stark & Barker LLP
`176 East Main Street, Suite 6
`Westborough, MA 01581
`(508) 366-3800/bbarker@chsblaw.com
`
`7
`
`
`
`Date: July 20, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Patent No. 6,806,652
`IPR2014-01089
`
`PATENT OWNER’S EXHIBIT LIST IPR 2014-00800
`
`Exhibit
`No.
`Ex. 2001
`
`Description
`
`Affidavit of Maria Granovsky in Support of
`Patent Owner’s Motion for Pro Hac Vice
`Admission
`
`Ex. 2002
`
`Declaration of Larry D. Hartsough, Ph.D.
`
`Ex. 2003
`
`Deposition of Dr. Kortshagen
`
`Ex. 2004
`
`Deposition of Dr. Korthshagen
`
`
`
`8
`
`
`
`
`
`
`
`
`
`Patent No. 6,806,652
`IPR2014-01089
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent
`
`Owner Observations were served via email on July, 20 2015, on Petitioner’s
`
`attorneys:
`
`dtennant@whitecase.com
`dchankong@whitecase.com
`david.cavanaugh@wilmerhale.com
`larissa.park@wilmerhale.com
`
`
`
`/Bruce Barker/
`Bruce Barker
`Reg. No. 33,291
`Chao Hadidi Stark & Barker LLP
`176 East Main Street, Suite 6
`Westborough, MA 01581
`(508) 366-3800
`bbarker@chsblaw.com
`
`9